CCL20 and eosinophilic esophagitis: Benralizumab tissues had higher RNA levels for factors involved in T cell proliferation and differentiation (i.e. IL-7 receptor [IL7R], IL-2 receptor subunit alpha [IL2RA], and chemokine ligand 20 [CCL20]) compared to active EoE.